Therapeutic recommendations from professional societies state that intermediate metabolizers may benefit less from tamoxifen therapy because they have lower concentrations of tamoxifen s major active metabolite, endoxifin, compared with normal metabolizers clomiphene 50mg





Reply With Quote
Bookmarks